» Articles » PMID: 32152071

Age-Dependent Effects of Type I and Type III IFNs in the Pathogenesis of Infection and Disease

Overview
Journal J Immunol
Date 2020 Mar 11
PMID 32152071
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Type I and III IFNs play diverse roles in bacterial infections, being protective for some but deleterious for others. Using RNA-sequencing transcriptomics we investigated lung gene expression responses to infection in adult mice, revealing that type I and III IFN pathways may play an important role in promoting inflammatory responses. In infected mice, lung type I/III IFN responses correlated with increased proinflammatory cytokine expression and with lung inflammatory pathology. In mutant mice with increased type I IFN receptor (IFNAR) signaling, infection exacerbated lung inflammatory pathology, whereas knockout mice with defects in type I IFN signaling had lower levels of lung inflammation than wild-type mice. Curiously, -infected IFNAR1 knockout mice had wild-type levels of lung inflammatory pathology. However, in response to infection these mice had increased levels of type III IFN expression, neutralization of which reduced lung inflammation. In support of this finding, -infected mice with a knockout mutation in the type III IFN receptor (IFNLR1) and double IFNAR1/IFNLR1 knockout mutant mice had reduced lung inflammatory pathology compared with that in wild-type mice, indicating that type III IFN exacerbates lung inflammation. In marked contrast, infant mice did not upregulate type I or III IFNs in response to infection and were protected from lethal infection by increased type I IFN signaling. These results indicate age-dependent effects of type I/III IFN signaling during infection and suggest that these pathways represent targets for therapeutic intervention in pertussis.

Citing Articles

Interferon lambda signaling in neutrophils enhances the pathogenesis of Bordetella pertussis infection.

Kumar A, Johnson D, Bukowski A, Noto M, Carbonetti N J Leukoc Biol. 2024; 117(2).

PMID: 39302155 PMC: 11879762. DOI: 10.1093/jleuko/qiae202.


Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection.

Antos D, Parks O, Duray A, Abraham N, Michel J, Kupul S PLoS Pathog. 2024; 20(8):e1012498.

PMID: 39178311 PMC: 11376568. DOI: 10.1371/journal.ppat.1012498.


ER-transiting bacterial toxins amplify STING innate immune responses and elicit ER stress.

Schlenker C, Richard K, Skobelkina S, Mathena R, Perkins D Infect Immun. 2024; 92(8):e0030024.

PMID: 39057915 PMC: 11321001. DOI: 10.1128/iai.00300-24.


The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.

Hardaker E, Sanseviero E, Karmokar A, Taylor D, Milo M, Michaloglou C Nat Commun. 2024; 15(1):1700.

PMID: 38402224 PMC: 10894296. DOI: 10.1038/s41467-024-45996-4.


Age-dependent natural killer cell and interferon γ deficits contribute to severe pertussis in infant mice.

Mitchell A, Scanlon K, Flowers E, Jordan C, Tibbs E, Bukowski A J Leukoc Biol. 2024; 115(6):1143-1153.

PMID: 38285898 PMC: 11135619. DOI: 10.1093/jleuko/qiae020.


References
1.
Zhang X, Deriaud E, Jiao X, Braun D, Leclerc C, Lo-Man R . Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med. 2007; 204(5):1107-18. PMC: 2118587. DOI: 10.1084/jem.20062013. View

2.
Schiavoni G, Mauri C, Carlei D, Belardelli F, Pastoris M, Proietti E . Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway. J Immunol. 2004; 173(2):1266-75. DOI: 10.4049/jimmunol.173.2.1266. View

3.
Espinosa V, Dutta O, McElrath C, Du P, Chang Y, Cicciarelli B . Type III interferon is a critical regulator of innate antifungal immunity. Sci Immunol. 2017; 2(16). PMC: 5880030. DOI: 10.1126/sciimmunol.aan5357. View

4.
Deaton A, Bird A . CpG islands and the regulation of transcription. Genes Dev. 2011; 25(10):1010-22. PMC: 3093116. DOI: 10.1101/gad.2037511. View

5.
Banus S, Pennings J, Vandebriel R, Wester P, Breit T, Mooi F . Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling. Immunogenetics. 2007; 59(7):555-64. PMC: 1914303. DOI: 10.1007/s00251-007-0227-5. View